Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY

v3.23.2
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($)
Total
Common Stock
Public Offering
Private Placement
Common Stock
ELOC Purchases
Common Stock
Preferred Stock
Preferred Stock
Series F Preferred Stock
Preferred Stock
Public Offering
Common Stock
Common Stock
Common Stock
Common Stock
Series F Preferred Stock
Common Stock
Public Offering
Common Stock
Private Placement
Common Stock
Common Stock
ELOC Purchases
Common Stock
Additional Paid-In Capital
Additional Paid-In Capital
Common Stock
Additional Paid-In Capital
Series F Preferred Stock
Additional Paid-In Capital
Public Offering
Additional Paid-In Capital
Private Placement
Common Stock
Additional Paid-In Capital
ELOC Purchases
Common Stock
Accumulated Deficit
Accumulated Other Comprehensive Loss
Balance at Dec. 31, 2021 $ 14,579,048         $ 0     $ 3,166           $ 135,541,662           $ (120,879,349) $ (86,431)
Balance (in shares) at Dec. 31, 2021           7     316,599                          
Stock-Based Compensation 287,175                           287,175              
Issuance of Common Stock from Panoptes Holdback Shares                 $ 100           (100)              
Issuance of Common Stock from Panoptes Holdback Shares (in shares)                 10,087                          
Foreign Currency Translation Adjustment (138,430)                                         (138,430)
Net Loss (5,965,825)                                       (5,965,825)  
Balance at Jun. 30, 2022 8,761,968         $ 0     $ 3,266           135,828,737           (126,845,174) (224,861)
Balance (in shares) at Jun. 30, 2022           7     326,686                          
Balance at Mar. 31, 2022 11,257,794         $ 0     $ 3,166           135,757,583           (124,444,363) (58,592)
Balance (in shares) at Mar. 31, 2022           7     316,599                          
Stock-Based Compensation 71,254                           71,254              
Issuance of Common Stock from Panoptes Holdback Shares                 $ 100           (100)              
Issuance of Common Stock from Panoptes Holdback Shares (in shares)                 10,087                          
Foreign Currency Translation Adjustment (166,269)                                         (166,269)
Net Loss (2,400,811)                                       (2,400,811)  
Balance at Jun. 30, 2022 8,761,968         $ 0     $ 3,266           135,828,737           (126,845,174) (224,861)
Balance (in shares) at Jun. 30, 2022           7     326,686                          
Balance at Dec. 31, 2022 11,407,600         $ 0     $ 17,986           146,035,314           (134,462,959) (182,741)
Balance (in shares) at Dec. 31, 2022           7     1,796,472                          
Stock-Based Compensation 307,736                           307,736              
Issuance of Common Stock and Preferred Stock     $ 5,595,962 $ 115,715 $ 442,310     $ 39       $ 21,976 $ 528 $ 1,250       $ 5,573,947 $ 115,187 $ 441,060    
Issuance of Preferred Stock (in shares)               3,908       2,197,628 52,798 125,000                
Issuance of Common Stock from Warrant Exercises   $ 298,500               $ 500           $ 298,000            
Issuance of Common Stock from Warrant Exercises (in shares)                   50,000                        
Conversion of Preferred Stock into Common Stock             $ (29)       $ 26,889           $ (26,859)          
Conversion of Preferred Stock into Common Stock (in shares)             (2,958)       2,688,822                      
Foreign Currency Translation Adjustment (43,120)                                         (43,120)
Net Loss (4,482,349)                                       (4,482,349)  
Balance at Jun. 30, 2023 13,642,355         $ 10     $ 69,129           152,744,385           (138,945,308) (225,861)
Balance (in shares) at Jun. 30, 2023           957     6,910,720                          
Balance at Mar. 31, 2023 10,155,509         $ 0     $ 19,214           146,683,202           (136,331,495) (215,412)
Balance (in shares) at Mar. 31, 2023           7     1,919,270                          
Stock-Based Compensation 171,795                           171,795              
Issuance of Common Stock and Preferred Stock     $ 5,595,962   $ 343,350     $ 39       $ 21,976   $ 1,050       $ 5,573,947   $ 342,300    
Issuance of Preferred Stock (in shares)               3,908       2,197,628   105,000                
Conversion of Preferred Stock into Common Stock             $ (29)       $ 26,889           $ (26,859)          
Conversion of Preferred Stock into Common Stock (in shares)             (2,958)       2,688,822                      
Foreign Currency Translation Adjustment (10,449)                                         (10,449)
Net Loss (2,613,813)                                       (2,613,813)  
Balance at Jun. 30, 2023 $ 13,642,355         $ 10     $ 69,129           $ 152,744,385           $ (138,945,308) $ (225,861)
Balance (in shares) at Jun. 30, 2023           957     6,910,720